Skip to main content
SpringerLink
Log in

Hemmung der intestinalen Leukotrien-Bildung als mögliches Wirkprinzip von Sulfasalazin, 5-Aminosalizylsäure und 4-Aminosalizylsäure

  • Pharmakologika: Aktuelles Aus Klinik Und Forschung Der Arzneitherapie
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ahnfelt-Ronne I, Haagen Nielsen O (1987) The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 21:191–194

    Google Scholar 

  2. Allgayer H, Stenson WF (1988) Role of lipoxygenase pathway products in an anmal model of colitis: effect of pretreatment with 5-lipoxygenase inhibitors. Gastroenterology 94:A6

    Google Scholar 

  3. Campieri M, Lanfranchi GA, Bazzochi G, Brignola C, Benatti A, Boccia S, Labo G (1980) Prostaglandins, indomethacin, and ulcerative colitis. Gastroenterology 78:193

    Google Scholar 

  4. Gilat T, Ratan J, Rosen P, Peled J (1979) Prostaglandins and ulcerative colitis. Gastroenterology 77:1083

    Google Scholar 

  5. Higgs GA, Moncada S, Vane JR (1984) Eicosanoids in inflammation. Ann Clin Res 16:287–299

    Google Scholar 

  6. Hoult JRS (1986) Pharmacological and biochemical actions of sulphasalazine. Drugs 32 (Suppl 1):18–26

    Google Scholar 

  7. Lauritsen K, Hansen J, Ryde M, Rask-Madsen J (1984) Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology 86:1496–1500

    Google Scholar 

  8. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J (1986) Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 91:837–844

    Google Scholar 

  9. Lobos EA, Sharon P, Stenson WF (1987) Chemotactic activity in inflammatory bowel disease: role of leukotriene B4. Dig Dis Sci 32:1380–1388

    Google Scholar 

  10. MacNaughton WK, Morris GP, Wallace JL (1988) Inhibition of leukotriene synthesis markedly enhances healing in a rat model of inflammatory bowel disease. Gastroenterology 94:A618

    Google Scholar 

  11. Montzka DM, Smith PL, Fondacaro JD (1987) Action of peptidoleukotrienes (PLTs) on electrolyte transport in rat small intestine. Gastroenterology 92:1803

    Google Scholar 

  12. Peskar BM, Dreyling KW, Peskar BA, May B, Goebell H (1986) Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition of sulfasalazine and 5-aminosalicylic acid. Agent Actions 18:381–383

    Google Scholar 

  13. Peskar BM, Dreyling KW, May B, Schaarschmidt K, Goebell H (1987) Possible mode of action of 5-aminosalicylic acid. Dig Dis Sci 32:51S-56S

    Google Scholar 

  14. Rampton DS, Hawkey CJ (1984) Prostaglandins and ulcerative colitis. Gut 25:1399–1413

    Google Scholar 

  15. Rampton DS, MacNeil NI, Sarner M (1983) Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 24:187–189

    Google Scholar 

  16. Rampton DS, Sladen GE (1981) Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment. Prostaglandins 21:417–425

    Google Scholar 

  17. Saverymuttu SH, Peters AM, Lavender JP, Chadwick VS, Hodgson HJ (1985) In vivo assessment of granulocytic migration to diseased bowel in Crohn's disease. Gut 26:378–383

    Google Scholar 

  18. Schlenker T, Peskar BM (1981) Dual effect of sulphasalazine on colonic prostaglandin synthetase. Lancet 2:815

    Google Scholar 

  19. Sharon P, Stenson WF (1984) Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453–460

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Experimentelle Klinische Medizin, Ruhr-Universität Bochum, Germany

    B. M. Peskar

Authors
  1. B. M. Peskar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peskar, B.M. Hemmung der intestinalen Leukotrien-Bildung als mögliches Wirkprinzip von Sulfasalazin, 5-Aminosalizylsäure und 4-Aminosalizylsäure. Klin Wochenschr 66, 1147–1150 (1988). https://doi.org/10.1007/BF01727854

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01727854

Search

Navigation